NCT06819657

Brief Summary

This study was designed to evaluate the safety and efficacy of remote ischemic conditioning (RIC) in patients with aneurysmal subarachnoid hemorrhage (aSAH) following surgical clipping. Aneurysmal subarachnoid hemorrhage is a life-threatening condition that occurs when a cerebral aneurysm ruptures, causing bleeding into the subarachnoid space. Surgical clipping of the aneurysm is a standard procedure used to stop the bleeding and prevent re-rupture, thereby stabilizing the patient's condition. Remote ischemic conditioning (RIC) is a non-invasive treatment that involves using a blood pressure cuff to induce brief, temporary cycles of ischemia and reperfusion in a limb. Research suggests that this process may confer systemic protective effects, potentially improving recovery from brain injury or surgery. Although RIC has shown potential to improve outcomes in patients with other neurological conditions, its effect on patients with aSAH who undergo surgical clipping remains unclear. This study will evaluate whether RIC can reduce complications, improve neurological function, and enhance overall recovery in these patients. The findings will help determine whether RIC should be incorporated into the standard treatment regimen for aSAH.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 11, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

March 10, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2026

Completed
Last Updated

September 9, 2025

Status Verified

August 1, 2025

Enrollment Period

10 months

First QC Date

February 5, 2025

Last Update Submit

September 8, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Proportion of mRS (0-2)

    Modified Rankin Scale, mRS; min:0, max:6; A smaller score indicates a better prognosis.

    90±7 days post-enrollment in the study

  • incidence rate of RIC adverse events

    RIC adverse events mainly include: limb pain, skin damage, deep vein thrombosis, transient hypertension, etc.

    From enrollment to the end of RIC at 1 week

Secondary Outcomes (3)

  • mRS Score as ordinal variable

    7±1 days post-enrollment in the study

  • mRS Score as ordinal variable

    30±7 days post-enrollment in the study

  • incidence rate of aSAH complications

    From enrollment to 90 days post-enrollment

Study Arms (2)

control group

OTHER

Guideline-based therapy

Other: Guideline-based therapy

RIC Group

EXPERIMENTAL

Guideline-based therapy + RIC (200 mmHg, bid, 7d)

Device: Remote Ischemic Conditioning Treatment InstrumentOther: Guideline-based therapy

Interventions

Remote ischemic conditioning (RIC) was administered twice daily to the unilateral lower limb using a blood pressure cuff inflated to 200 mmHg for 7 consecutive days post-clipping

RIC Group

Guideline-based therapy

RIC Groupcontrol group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Imaging examination confirmed aneurysmal subarachnoid hemorrhage.
  • Responsible aneurysms received craniotomy clipping within 24 hours.
  • ≤ age ≤80 years old.
  • Informed consent of the participant or legally authorized representative

You may not qualify if:

  • Patients with other types of cerebral hemorrhage.
  • Prior neurological impairment (mRS Score \>1) or mental illness may confuse neurological or functional assessment.
  • Severe comorbidities with a life expectancy of less than 90 days.
  • Refractory hypertension (systolic blood pressure 180\>mmHg or diastolic blood pressure 110\>mmHg).
  • RIC contraindications: severe soft tissue injury of lower limbs.
  • Simultaneously participate in another research program to study a different experimental therapy.
  • Any condition that the investigator believes may increase the patient's risk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan Hospital

Beijing, Beijing Municipality, 100000, China

RECRUITING

Related Publications (1)

  • Xu L, Jin T, Niu H, Yin Y, Yan K, Guan H, Liu A. Remote ischemic conditioning for safety, feasibility and preliminary efficacy of patients with aneurysmal subarachnoid hemorrhage after aneurysm clipping, design, and protocol for an open-label, evaluator blinding randomized controlled trial. Front Neurol. 2025 Nov 20;16:1650773. doi: 10.3389/fneur.2025.1650773. eCollection 2025.

MeSH Terms

Conditions

Subarachnoid HemorrhageCerebrovascular DisordersBrain DiseasesStrokeCardiovascular DiseasesVascular DiseasesNervous System Diseases

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCentral Nervous System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2025

First Posted

February 11, 2025

Study Start

March 10, 2025

Primary Completion

December 30, 2025

Study Completion

March 30, 2026

Last Updated

September 9, 2025

Record last verified: 2025-08

Locations